Todd Allen, MD
Obstetrics · Dearborn, MINPI 1063492494
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 26.5% of the total. That places this record below the midpoint for obstetrics clinicians in MI, where the typical reported total is $841.
Across 41 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$204
- Sage Therapeutics, LLC$164
- Hologic Sales And Service, LLC$87
- Optumhealth Care Solutions, LLC$78
- Astellas Pharma US Inc$72
- Organon$54
- plus $110 from 5 others
What the payments were for
- Travel & lodging$61%
- Food & beverage$76299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $204 |
| Sage Therapeutics, LLC | 6 | $164 |
| Hologic Sales And Service, LLC | 3 | $87 |
| Optumhealth Care Solutions, LLC | 2 | $78 |
| Astellas Pharma US Inc | 3 | $72 |
| Organon | 3 | $54 |
| Merck | 3 | $41 |
| Novo Nordisk | 2 | $28 |
| Bayer | 2 | $24 |
| Duchesnay USA Incorporated | 1 | $11 |
| Intuitive Surgical | 1 | $6 |
How this compares
$768 in reported general payments places this provider in the 45th percentile of 48 obstetrics providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $4,235 |
| ValacyclovirValacyclovir Hcl | 24 | $1,444 |
| Estradiol (Once Weekly)Estradiol | 25 | $1,232 |
| Metronidazole | 25 | $140 |
| Ondansetron OdtOndansetron | 11 | $125 |
| Fluconazole | 19 | $123 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Dearborn
- Duane KreilDearborn$5K
- Eiliana BitarDearborn$1K
- Karen PlymelDearborn$431
- Maria KossakDearborn$114
- Carol PowersFlint$327K
- Alexey LevashkevichFlint$23K
- Breanna PondMarquette$18K
- Richard ElsworthFlint$17K
- Salvatore FinazzoTrenton$13K
- Jack ParksMuskegon$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.